CpG motifs in bacterial DNA trigger direct B-cell activation
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Unmethylated CpG dinucleotides are more frequent in the genomes of bacteria and viruses than of vertebrates. We report here that bacterial DNA and synthetic oligodeoxynucleotides containing unmethylated CpG dinucleotides induce murine B cells to proliferate and secrete immunoglobulin in vitro and in vivo. This activation is enhanced by simultaneous signals delivered through the antigen receptor. Optimal B-cell activation requires a DNA motif in which an unmethylated CpG dinucleotide is flanked by two 5' purines and two 3' pyrimidines. Oligodeoxynucleotides containing this CpG motif induce more than 95% of all spleen B cells to enter the cell cycle. These data suggest a possible evolutionary link between immune defence based on the recognition of microbial DNA and the phenomenon of 'CpG suppression' in vertebrates. The potent immune activation by CpG oligonucleotides has implications for the design and interpretation of studies using 'antisense' oligonucleotides and points to possible new applications as adjuvants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unmethylated CpG motifs in bacterial DNA are potent triggers of inflammation (Klinman et al., 1997; Krieg et al., 1995).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Krieg et al., 1995
In the citing paper
“CpG DNA is a potent stimulator of TLR9 (12).”
From Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice (2011) · cites this paper as [12]
Citations
Cites
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
Gene inhibition using antisense oligodeoxynucleotides
Wagner, R. W. (1994) · Nature · doi:10.1038/372333a0 · Cited by 736
CpG islands as gene markers in the vertebrate nucleus
Bird, A. P. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90294-0 · Cited by 678
Current concepts in antisense drug design
Milligan, J. F., Matteucci, M. D., & Martin, J. C. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00066a001 · Cited by 566
Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., & Johnson, M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331109 · Cited by 562
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Agrawal, S., Temsamani, J., & Tang, J. Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7595 · Cited by 561
Therapeutic Applications of Oligonucleotides
Crooke, S. T. (1992) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.32.040192.001553 · Cited by 446
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
Messina, J. P., Gilkeson, G. S., & Pisetsky, D. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.6.1759 · Cited by 371
Lymphocyte stimulation: a rapid multiparameter analysis.
Darzynkiewicz, Z., Traganos, F., Sharpless, T., & Melamed, M. R. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.8.2881 · Cited by 347
Frequency of B lymphocytes responsive to anti-immunoglobulin.
Defranco, A. L., Raveche, E. S., Asofsky, R., & Paul, W. E. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.5.1523 · Cited by 293
Research works printed but not linked: 1
- Krapf, F., Herrmann, M., Leitmann, W. & Kalden, J. R. Clin. exp. immun. 75, 336–342 (1989).
Cited by
Items 301–400 of 1,013
Brunner, C., Seiderer, J., Schlamp, A., Bidlingmaier, M., Eigler, A., Haimerl, W., Lehr, H.-A., Krieg, A. M., Hartmann, G., & Endres, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6278 · Cited by 192
Self-citationMozdzanowska, K., Feng, J., Eid, M., Kragol, G., Cudic, M., Otvos, L., & Gerhard, W. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00040-9 · Cited by 194
Loiarro, M., Capolunghi, F., Fantò, N., Gallo, G., Campo, S., Arseni, B., Carsetti, R., Carminati, P., De Santis, R., Ruggiero, V., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1206746 · Cited by 189
Development of the CpG Adjuvant 1018: A Case Study
Campbell, J. D. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6445-1_2 · Cited by 189
Fomivirsen – a phosphorothioate oligonucleotide for the treatment of CMV retinitis
de Smet, M. D., Meenken, C., & van den Horn, G. J. (1999) · Ocular Immunology and Inflammation · doi:10.1076/ocii.7.3.189.4007 · Cited by 187
Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides
Suzuki, K., Mori, A., Ishii, K. J., Saito, J., Singer, D. S., Klinman, D. M., Krause, P. R., & Kohn, L. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2285 · Cited by 194
Self-citationNeonatal immunity: how well has it grown up?
Marshall-Clarke, S., Reen, D., Tasker, L., & Hassan, J. (2000) · Immunology Today · doi:10.1016/s0167-5699(99)01548-0 · Cited by 190
Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9
Takeshita, F., Gursel, I., Ishii, K. J., Suzuki, K., Gursel, M., & Klinman, D. M. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.009 · Cited by 189
Self-citationBennett, C. F., Kornbrust, D., Henry, S., Stecker, K., Howard, R., Cooper, S., Dutson, S., Hall, W., & Jacoby, H. I. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36471-7 · Cited by 190
High‐mobility group box‐1 in sterile inflammation
Tsung, A., Tohme, S., & Billiar, T. R. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12276 · Cited by 187
Recent Advances in Oligonucleotide Therapeutics in Oncology
Xiong, H., Veedu, R. N., & Diermeier, S. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073295 · Cited by 189
Bost, J. P., Barriga, H., Holme, M. N., Gallud, A., Maugeri, M., Gupta, D., Lehto, T., Valadi, H., Esbjörner, E. K., Stevens, M. M., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c05099 · Cited by 184
Hu, Y., Gao, S., Lu, H., & Ying, J. Y. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c13426 · Cited by 183
Gururajan, M., Jacob, J., & Pulendran, B. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000863 · Cited by 185
DNA Binding-Uptake System: a Link between Cell-to-Cell Communication and Biofilm Formation
Petersen, F. C., Tao, L., & Scheie, A. A. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.13.4392-4400.2005 · Cited by 186
Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice.
Carpentier, A. F., Chen, L., Maltonti, F., & Delattre, J. (1999) · PubMed · Cited by 185
Toll-Like Receptor 9 Affects Severity of IgA Nephropathy
Suzuki, H., Suzuki, Y., Narita, I., Aizawa, M., Kihara, M., Yamanaka, T., Kanou, T., Tsukaguchi, H., Novak, J., Horikoshi, S., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121311 · Cited by 187
Gnopo, Y. M. D., Watkins, H. C., Stevenson, T. C., DeLisa, M. P., & Putnam, D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.003 · Cited by 184
CpG Still Rocks! Update on an Accidental Drug
Krieg, A. M. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0340 · Cited by 187
Self-citationResistance to CpG DNA–induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling
Rui, L., Vinuesa, C. G., Blasioli, J., & Goodnow, C. C. (2003) · Nature Immunology · doi:10.1038/ni924 · Cited by 185
Immune Sensing Mechanisms that Discriminate Self from Altered Self and Foreign Nucleic Acids
Bartok, E., & Hartmann, G. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.014 · Cited by 182
Krieg, A. M., Efler, S. M., Wittpoth, M., Al Adhami, M. J., & Davis, H. L. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200411000-00006 · Cited by 184
Self-citationImmune effects and mechanisms of action of CpG motifs
Krieg, A. M. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00249-8 · Cited by 181
Self-citationWagner, H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00144-3 · Cited by 181
The experimental use of antisense oligonucleotides: a guide for the perplexed
Stein, C. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13885 · Cited by 183
Regulatory Roles for Cytokine- Producing B Cells in Infection and Autoimmune Disease
Lund, F. E., Garvy, B. A., Randall, T. D., & Harris, D. P. (2004) · Current Directions in Autoimmunity · doi:10.1159/000082086 · Cited by 181
Gursel, I., Gursel, M., Ishii, K. J., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3324 · Cited by 182
Self-citationImportance of nucleotide sequence and chemical modifications of antisense oligonucleotides
Agrawal, S. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00141-4 · Cited by 179
Locked Nucleic Acid: A Potent Nucleic Acid Analog in Therapeutics and Biotechnology
Jepsen, J. S., Sørensen, M. D., & Wengel, J. (2004) · Oligonucleotides · doi:10.1089/1545457041526317 · Cited by 179
Morpholino and Phosphorothioate Antisense Oligomers Compared in Cell-Free and In-Cell Systems
SUMMERTON, J., STEIN, D., HUANG, S. B., MATTHEWS, P., WELLER, D., & PARTRIDGE, M. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.63 · Cited by 179
Freimark, B. D., Blezinger, H. P., Florack, V. J., Nordstrom, J. L., Long, S. D., Deshpande, D. S., Nochumson, S., & Petrak, K. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4580 · Cited by 180
Diwan, M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00275-4 · Cited by 177
McCluskie, M. J., Millan, C. L. B., Gramzinski, R. A., Robinson, H. L., Santoro, J. C., Fuller, J. T., Widera, G., Haynes, J. R., Purcell, R. H., & Davis, H. L. (1999) · Molecular Medicine · doi:10.1007/bf03402065 · Cited by 176
Natural resistance and nitric oxide
Nathan, C. (1995) · Cell · doi:10.1016/0092-8674(95)90019-5 · Cited by 178
The Expression and Functions of Toll-Like Receptors in Atherosclerosis
Cole, J. E., Georgiou, E., & Monaco, C. (2010) · Mediators of Inflammation · doi:10.1155/2010/393946 · Cited by 177
Effect of different chemically modified oligodeoxynucleotides on immune stimulation
Zhao, Q., Temsamani, J., Iadarola, P. L., Jiang, Z., & Agrawal, S. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02177-9 · Cited by 176
Do DNA Vaccines Induce Autoimmune Disease?
Mor, G., Singla, M., Steinberg, A. D., Hoffman, S. L., Okuda, K., & Klinman, D. M. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.3-293 · Cited by 177
Self-citationModulating the immune response to genetic immunization
Cohen, A. D., Boyer, J. D., & Weiner, D. B. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1611 · Cited by 177
Ilyinskii, P. O., Roy, C. J., O’Neil, C. P., Browning, E. A., Pittet, L. A., Altreuter, D. H., Alexis, F., Tonti, E., Shi, J., Basto, P. A., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.02.027 · Cited by 171
The Molecular Basis for the Lack of Immunostimulatory Activity of Vertebrate DNA
Stacey, K. J., Young, G. R., Clark, F., Sester, D. P., Roberts, T. L., Naik, S., Sweet, M. J., & Hume, D. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3614 · Cited by 174
Recent progress concerning CpG DNA and its use as a vaccine adjuvant
Shirota, H., & Klinman, D. M. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.863715 · Cited by 172
Self-citationBarry, M. E., Pinto-Gonzalez, D., Orson, F. M., McKenzie, G. J., Petry, G. R., & Barry, M. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950016816 · Cited by 173
Nemunaitis, J., Holmlund, J. T., Kraynak, M., Richards, D., Bruce, J., Ognoskie, N., Kwoh, T. J., Geary, R., Dorr, A., Von Hoff, D., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3586 · Cited by 173
Plant Hormesis Management with Biostimulants of Biotic Origin in Agriculture
Vargas-Hernandez, M., Macias-Bobadilla, I., Guevara-Gonzalez, R. G., Romero-Gomez, S. D. J., Rico-Garcia, E., Ocampo-Velazquez, R. V., Alvarez-Arquieta, L. D. L., & Torres-Pacheco, I. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.01762 · Cited by 169
Inhibition of tumorigenesis by a cytosine–DNA, methyltransferase, antisense oligodeoxynucleotide
Ramchandani, S., MacLeod, A. R., Pinard, M., von Hofe, E., & Szyf, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.684 · Cited by 172
TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)
Weeratna, R. D., Makinen, S. R., McCluskie, M. J., & Davis, H. L. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.06.024 · Cited by 170
An Anti-Inflammatory Role for Plasmacytoid Dendritic Cells in Allergic Airway Inflammation
Kool, M., van Nimwegen, M., Willart, M. A. M., Muskens, F., Boon, L., Smit, J. J., Coyle, A., Clausen, B. E., Hoogsteden, H. C., Lambrecht, B. N., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900471 · Cited by 169
Systemic application of CpG‐rich DNA suppresses adaptive T cell immunity via induction of IDO
Wingender, G., Garbi, N., Schumak, B., Jüngerkes, F., Endl, E., von Bubnoff, D., Steitz, J., Striegler, J., Moldenhauer, G., Tüting, T., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200535602 · Cited by 170
Causes and Implications of Codon Usage Bias in RNA Viruses
Belalov, I. S., & Lukashev, A. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056642 · Cited by 169
Tissue engineering via local gene delivery:
Bonadio, J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00094-6 · Cited by 168
Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors.
Resnicoff, M., Burgaud, J., Rotman, H. L., Abraham, D., & Baserga, R. (1995) · PubMed · Cited by 168
Weiss, W. R., Ishii, K. J., Hedstrom, R. C., Sedegah, M., Ichino, M., Barnhart, K., Klinman, D. M., & Hoffman, S. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2325 · Cited by 169
Self-citationJones, T. R., Obaldia, N., Gramzinski, R. A., Charoenvit, Y., Kolodny, N., Kitov, S., Davis, H. L., Krieg, A. M., & Hoffman, S. L. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00145-0 · Cited by 167
Self-citationAntisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?
Rayburn, E. R., & Zhang, R. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.03.014 · Cited by 168
Protection of Chickens against Escherichia coli Infections by DNA Containing CpG Motifs
Gomis, S., Babiuk, L., Godson, D. L., Allan, B., Thrush, T., Townsend, H., Willson, P., Waters, E., Hecker, R., & Potter, A. (2003) · Infection and Immunity · doi:10.1128/iai.71.2.857-863.2003 · Cited by 165
A good antisense molecule is hard to find
Branch, A. D. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01155-9 · Cited by 168
How Location Governs Toll‐Like Receptor Signaling
Chaturvedi, A., & Pierce, S. K. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00899.x · Cited by 164
Eckl-Dorna, J., & Batista, F. D. (2009) · Blood · doi:10.1182/blood-2008-10-185421 · Cited by 163
TLR Stimulation Modifies BLyS Receptor Expression in Follicular and Marginal Zone B Cells
Treml, L. S., Carlesso, G., Hoek, K. L., Stadanlick, J. E., Kambayashi, T., Bram, R. J., Cancro, M. P., & Khan, W. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7531 · Cited by 161
Plasmacytoid dendritic cells: the key to CpG
Rothenfusser, S., Tuma, E., Endres, S., & Hartmann, G. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00749-8 · Cited by 164
Klinman, D. M., Conover, J., & Coban, C. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.5658-5663.1999 · Cited by 163
Self-citationToll-like receptors and innate immunity in B-cell activation and antibody responses
Lanzavecchia, A., & Sallusto, F. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.04.002 · Cited by 162
Understanding and making use of human memory B cells
Lanzavecchia, A., Bernasconi, N., Traggiai, E., Ruprecht, C. R., Corti, D., & Sallusto, F. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00403.x · Cited by 162
Peptide Conjugates of Oligonucleotides: Synthesis and Applications
Venkatesan, N., & Kim, B. H. (2006) · Chemical Reviews · doi:10.1021/cr0502448 · Cited by 161
Jounai, N., Kobiyama, K., Takeshita, F., & Ishii, K. J. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00168 · Cited by 162
Immunostimulatory CpG-DNA Activates Murine Microglia
Dalpke, A. H., Schäfer, M. K.-H., Frey, M., Zimmermann, S., Tebbe, J., Weihe, E., & Heeg, K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4854 · Cited by 163
Palaniyar, N., Nadesalingam, J., Clark, H., Shih, M. J., Dodds, A. W., & Reid, K. B. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403763200 · Cited by 162
Shirota, H., Sano, K., Kikuchi, T., Tamura, G., & Shirato, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5575 · Cited by 163
A role for NF-κB–dependent gene transactivation in sunburn
Abeyama, K., Eng, W., Jester, J. V., Vink, A. A., Edelbaum, D., Cockerell, C. J., Bergstresser, P. R., & Takashima, A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9745 · Cited by 160
“The CpG motif, originally identified in bacterial DNA (51), is now known to stimulate both humoral and cellular immune responses via acting on B cells, macrophages, dendritic cells, natural killer cells, and T cells and to control the balance between the Th1- and Th2-type immune responses (52–55).”
BackgroundGiese, N. A., Gabriele, L., Doherty, T. M., Klinman, D. M., Tadesse-Heath, L., Contursi, C., Epstein, S. L., & Morse, H. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1535 · Cited by 160
Self-citationBDCA2/FcεRIγ Complex Signals through a Novel BCR-Like Pathway in Human Plasmacytoid Dendritic Cells
Cao, W., Zhang, L., Rosen, D. B., Bover, L., Watanabe, G., Bao, M., Lanier, L. L., & Liu, Y.-J. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050248 · Cited by 162
Progress in antisense technology: The end of the beginning
Crooke, S. T. (2000) · Methods in Enzymology · doi:10.1016/s0076-6879(00)13003-4 · Cited by 160
Harandi, A. M., Eriksson, K., & Holmgren, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.2.953-962.2003 · Cited by 161
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors
Christensen, S. R., & Shlomchik, M. J. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2006.12.005 · Cited by 161
Borges, O., Cordeiro-da-Silva, A., Tavares, J., Santarém, N., de Sousa, A., Borchard, G., & Junginger, H. E. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.01.019 · Cited by 158
Kovarik, J., Bozzotti, P., Love-Homan, L., Pihlgren, M., Davis, H. L., Lambert, P.-H., Krieg, A. M., & Siegrist, C.-A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1611 · Cited by 160
Self-citationBozza, S., Gaziano, R., Lipford, G. B., Montagnoli, C., Bacci, A., Di Francesco, P., Kurup, V. P., Wagner, H., & Romani, L. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)00007-2 · Cited by 158
Innovative strategies for co-delivering antigens and CpG oligonucleotides
Krishnamachari, Y., & Salem, A. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.013 · Cited by 175
What happens to the DNA vaccine in fish? A review of current knowledge
Tonheim, T. C., Bøgwald, J., & Dalmo, R. A. (2008) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2008.03.007 · Cited by 157
Wagner, M., Poeck, H., Jahrsdoerfer, B., Rothenfusser, S., Prell, D., Bohle, B., Tuma, E., Giese, T., Ellwart, J. W., Endres, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.954 · Cited by 157
McCluskie, M. J., & Davis, H. L. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00208-5 · Cited by 157
Mucosal vaccine delivery: Current state and a pediatric perspective
Shakya, A. K., Chowdhury, M. Y. E., Tao, W., & Gill, H. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.014 · Cited by 171
Jahrsdörfer, B., Blackwell, S. E., Wooldridge, J. E., Huang, J., Andreski, M. W., Jacobus, L. S., Taylor, C. M., & Weiner, G. J. (2006) · Blood · doi:10.1182/blood-2006-03-014001 · Cited by 154
Agrawal, S., & Gupta, S. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9456-8 · Cited by 155
Nucleic acid-binding polymers as anti-inflammatory agents
Lee, J., Sohn, J. W., Zhang, Y., Leong, K. W., Pisetsky, D. S., & Sullenger, B. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105777108 · Cited by 155
Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN
Vasilakos, J. P., Smith, R. M., Gibson, S. J., Lindh, J. M., Pederson, L. K., Reiter, M. J., Smith, M. H., & Tomai, M. A. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1689 · Cited by 155
CpG DNA: A pathogenic factor in systemic lupus erythematosus?
Krieg, A. Μ. (1995) · Journal of Clinical Immunology · doi:10.1007/bf01541318 · Cited by 155
Self-citationSun, S., Kishimoto, H., & Sprent, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1145 · Cited by 158
Lin, Y., Chen, L., Liao, C., Yeh, C., Ma, S.-H., Chen, J., Huang, Y.-L., Chen, S., & Chiang, H.-Y. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.191-200.1998 · Cited by 154
Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides
Krieg, A. Μ. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00147-5 · Cited by 154
Self-citationGramzinski, R. A., Doolan, D. L., Sedegah, M., Davis, H. L., Krieg, A. Μ., & Hoffman, S. L. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1643-1649.2001 · Cited by 170
Self-citationHofmann, M. A., Kors, C., Audring, H., Walden, P., Sterry, W., & Trefzer, U. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318174a4df · Cited by 153
A mouse model for HBV immunotolerance and immunotherapy
Yang, D., Liu, L., Zhu, D., Peng, H., Su, L., Fu, Y., & Zhang, L. (2013) · Cellular and Molecular Immunology · doi:10.1038/cmi.2013.43 · Cited by 161
Mason, K. A., Ariga, H., Neal, R. E., Valdecanas, D. R., Hunter, N. R., Krieg, A. Μ., Whisnant, J. K., & Milas, L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.361.11.1 · Cited by 164
Self-citationSegal, B. M., Chang, J. T., & Shevach, E. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5683 · Cited by 154
Link, B. K., Ballas, Z. K., Weisdorf, D., Wooldridge, J. E., Bossler, A. D., Shannon, M., Rasmussen, W. L., Krieg, A. M., & Weiner, G. J. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211304.60126.8f · Cited by 155
Self-citationBacterial DNA evokes epithelial IL‐8 production by a MAPK‐dependent, NFκB‐independent pathway
Akhtar, M., Watson, J. L., Nazli, A., & McKay, D. M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0950fje · Cited by 152
Anderson, K., Fox, M., Brown‐Driver, V., Martin, M., & Azad, R. F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2004 · Cited by 153
Giovannangeli, C., Diviacco, S., Labrousse, V., Gryaznov, S. M., Charneau, P., & Hélène, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.79 · Cited by 153
Wang, S., Liu, H., Zhang, X., & Qian, F. (2015) · Protein & Cell · doi:10.1007/s13238-015-0164-2 · Cited by 151
Metadata
- Authors
- Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M.
- Affiliations
- University of Iowa (US)
- Center for Biologics Evaluation and Research (US)
- ORCID
- Venue
- Nature
- Published
- 1995-04
- Volume
- 374
- Issue
- 6522
- Pages
- 546-549
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2047366876
- Cited by
- 3,508
- References
- 28
- Citations by year
- 2026: 24 · 2025: 36 · 2024: 47 · 2023: 43 · 2022: 58 · 2021: 58 · 2020: 84 · 2019: 84 · 2018: 58 · 2017: 69 · 2016: 76 · 2015: 89 · 2014: 83 · 2013: 102 · 2012: 104
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- CpG motifs, bacterial DNA, B cell activation, B cell proliferation, immunoglobulin secretion, antigen receptor signaling, CpG oligodeoxynucleotides, CpG suppression, antisense oligonucleotides, adjuvants
- MeSH terms
- Animals, B-Lymphocytes, Base Sequence, Cell Line, DNA, Bacterial, Escherichia coli, Lymphocyte Activation, Methylation, Mice, Inbred DBA, Molecular Sequence Data, Oligodeoxyribonucleotides, T-Lymphocytes, Dinucleoside Phosphates, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.